Faculty

FINAL PROGRAM
Friday April 19th, 2013
14:00

Herbert Frank (Tulln, Austria)

14:10 – 15:00
Session I
IMAGING PROTOCOLS
Chair:

Herbert Frank (Tulln, Austria)
Udo Hoffmann (Boston, USA)
State of the art CT Image Protocols and
Postprocessing
Koen Nieman (Rotterdam, The Netherlands)

State of the art CMR Image Protocols and
Postprocessing
Holger Thiele (Leipzig, Germany)

15:00 - 16:36
Session II
CLINICAL CASE PRESENTATIONS I
Chair:

Herbert Frank (Tulln, Austria)
Charles Higgins (San Francisco, USA)
Udo Hoffmann (Boston, USA)
Philipp Kaufmann (Zurich, Switzerland)
Koen Nieman (Rotterdam, The Netherlands)
Günter Stix (Vienna, Austria)
Oliver Bruder (Essen, Germany)
Peter Buser (Basel, Switzerland)
Holger Thiele (Leipzig, Germany)
Udo Sechtem (Stuttgart, Germany)

17:00 – 18:00
SessionIII
MY PERSONAL EXPERIENCE CT/MRI
Chair:

Holger Thiele (Leipzig, Germany)
Koen Nieman (Rotterdam, Netherlands)
Tips and Tricks CMR
Charles Higgins (San Francisco, USA)
Tips and Tricks CT
Jörg Hausleiter (Munich, Germany)
Reception
with Poster Presentations
Poster Presentations A
Peter Buser (Basel, Switzerland)
Koen Nieman (Rotterdam, Netherlands)

19:00 – 19:05
P1: Cardiac MRI in reperfused STEMI: prognostic
stratification using dedicated software tools
Elisabetta Chiodi (Ferreira, Italy)
P2: Potential of multi-slice computed tomography in
assessment of mitral valve and left ventricular
reverse remodeling after surgical repair
Natalia Solowjowa (Berlin, Germany)
P3: Post-traumatic cardiac herniation: late diagnosis
with cardiac MR
Elena Perlasca (Bergamo, Italy)

P4: Myocarditis induced by Mesalamine: A Case
Report
Elisa Rauseo (Rome, Italy)
Poster Presentations B
Jörg Hausleiter (Munich, Germany)
Oliver Bruder (Essen, Germany)

19:00 – 19:05
P5: Do we get an Accurate Impression about Left
Ventricular Geometry with Prospective Gated 320
slice CT Coronary Angiogram Studies? Implications
for CT coronary angiography reporting.
Stuart Moir (Melbourne, Australia)
P6: Measurement of trabeculated left ventricular
mass using cardiac magnetic in thalassemia
patients and correlation with clinical and functional
cardiac parameters
Elisabetta Chiodi (Ferreira, Italy)
P7: Sudden Death in Young - Causes and
Morphological Finding (including Magnetic
Resonance): Data from Latvian Registry 2011
Ligita Zvaigzne (Riga, Latvia)
P8: Imaging support with multi-slice computed
tomography for surgical restoration of dyskinetic
anteroapical left ventricular aneurysm: single center
experience
Natalia Solowjowa (Berlin, Germany)
P9: Role and cost-effectiveness of a stress imaging
guided strategy in patients with non-culprit lesion at
primary percutaneous coronary intervention
Marco Cengarle (Bristol, UK)
Saturday April 20th, 2013
09:00 – 10:20
Session IV
HEART

FAILURE: DIAGNOSIS AND RISK
STRATIFICATION
Chair:
Udo Sechtem (Stuttgart, Germany)
Peter Buser (Basel, Switzerland)
Main lecture: Non ischemic heart failure: Clinical
and therapeutic aspects
Farouc Jaffer (Boston, USA)
Diagnosing non-ischemic CMP: ECHO is the gold-
standard
Raphael Rosenhek (Vienna, Austria)
CCT and CMR: The better choice in non-ischemic
HF management
Herbert Frank (Tulln, Austria)
Panel:
Farouc Jaffer (Boston, USA)
Raphael Rosenhek (Vienna, Austria)
Herbert Frank (Tulln, Austria)

10:40 - 12:00
Session V
CORONARY ARTERY DISEASE: DIAGNOSIS
AND RISK STRATIFICATION
Chair:

Farouc Jaffer (Boston, USA)
Charles Higgins (San Francisco, USA)
Main lecture: Atherosclerosis Imaging for risk stratification and discovery of novel effective treatments Ahmed Tawakol (Boston, USA)
A paradigm shift: CAC and CCT to select candidate
therapies and guide medical therapy
Udo Hoffmann (Boston, USA)
CMR: Comprehensive assessment of CHD
Holger Thiele (Leipzig, Germany)
Panel:
Ahmed Tawakol (Boston, USA)
Udo Hoffmann (Boston, USA)
Holger Thiele (Leipzig, Germany
)

13:40 – 14:40
Session VI
CHANGING PARADIGMS IN CARDIAC IMAGING
Chair:

Filippo Civaia (Monaco)
Günther Stix (Austria, Vienna)
T1 time measurements
Charles Higgins (San Francisco, USA)

MR Compatibility of PM systems
Oliver Bruder (Essen, Germany)
Assessement of myocardial flow and perfusion by
CT
Koen Nieman (Rotterdam, The Netherlands)
14:40–15:00
Session VII
INDUSTRY FORUM – CMR
Chair:

Oliver Bruder (Essen, Germany)
Filippo Civaia (Monaco)
Lars Drüppel (Siemens)
14:50- 15:00 CMR application seamlessly integratable in clinical Yuko Yamamoto (Medis)

15.20 - 16.40
Session VIII
THE

ISCHEMIC
BURDEN: what the
interventional cardiologist and cardiac surgeon
learned from noninvasive imaging techniques
Chair:

Pierre Monney (Lausanne, Switzerland)
Holger Thiele (Leipzig, Germany)
Main lecture: Traditional diagnosis of ischemic and Ahmed Tawakol (Boston, USA)
Preinterventional assessment of viable myocardium
in ischemic heart failure
Udo Sechtem (Stuttgart, Germany)
Planning complex coronary interventions: How
helpful is CCT
Thomas Brunner (Vienna, Austria)
Panel:
Ahmed Tawakol (Boston, USA)
Udo Sechtem
(Stuttgart, Germany)
Thomas Brunner
(Vienna, Austria)

16:40 – 18:00
Session IX
CONTROVERSIES IN NONINVASIVE IMAGING:
What is the gold standard for hemodynamic
significance – The Bermuda triangle of myo
cardial ischemia, coronary morphology, and
FFR
Chair:

Ahmed Tawakol (Boston, USA)
Udo Sechtem (Stuttgart, Germany)
We still need the invasive assessment of
hemodynamically significance in CAD
Thomas Brunner (Vienna, Austria)
CCT – an efficient gatekeeper to ICA and on its way
to more
Udo Hoffmann (Boston, USA)
CMR – Assessment of stress perfusion deficit as prerequisites for the intervention Pierre Monney (Lausanne, Switzerland)
Panel:
Thomas Brunner
(Vienna, Austria)
Udo Hoffmann
(Boston, USA)
Pierre Monney
(Lausanne, Switzerland)

18:00-19:00
Session X
CLINICAL CASE PRESENTATIONS II
Chair:

Thomas Brunner (Vienna, Austria)
Farouc Jaffer (Boston, USA)

18:00 – 18:30
Ahmed Tawakol (Boston, USA)
Koen Nieman (Rotterdam, The Netherlands)
Philipp Kaufmann (Zürich, Switzerland)
Udo Hoffmann (Boston, USA)
Filippo Civaia (Monaco)
Charles Higgins (San Francisco, USA)
Farouc Jaffer (Boston, USA)
Herbert Frank (Tulln, Austria)
Social Event
Sunday, April 21st, 2013
09:00 - 09:30
POSTER PRIZE PRESENTATION
Herbert Frank (Tulln, Austria)
Udo Hoffmann (Boston, USA)
Short presentation of the awarded posters by the authors
09:30 – 10:30

Session XI
SAFETY CONSIDERATIONS IN CV IMAGING
CHAIR: Herbert Frank
(Tulln, Austria)
Udo Hoffmann (Boston, USA)
Radiation Exposures in Cardiac CT and low dose
volume CT
Philipp Kaufmann (Zurich, Switzerland)
New developments for contrast agents
Gertraud Heinz (St. Pölten, Austria)

10:50 - 11:10

Session XII
INDUSTRY FORUM – CT
Chair:

Jörg Hausleiter (Munich, Germany)
Udo Hoffmann (Boston, USA)
Automated Assessment of the Aortic Root Anatomy for TAVI-Planning: Clinical Evaluation and Live Presentation Philipp Blanke (Freiburg, Germany) for Siemens
Strategies for radiation dose reduction in vascular CT Marco Francone (Rome, Italy) for Bracco
Validated CTA plaque analysis application Yuko Yamamoto (Medis)

11:20 – 12.20
Session XIII
IMAGING AS PREOPERATIVE GUIDING
Chair:

Raphael Rosenhek (Vienna, Austria)
Thomas Brunner (Vienna, Austria)
TAVI
Jörg Hausleiter (Munich, Germany)

Pediatric and adult congenital heart disease
Filippo Civaia (Monaco)

Cardiac Imaging in Electrophysiology –
The Electrophysiologist’s view
Günter Stix (Vienna, Austria)

12.20-12:50
Session XIV
MY TOP TEN CLINICAL INDICATIONS
Chair:

Philipp Kaufmann (Zurich, Switzerland)
Gertraud Heinz (St. Pölten, Austria)
Udo Hoffmann (Boston, USA)
Cardiovascular MR
Peter Buser (Basel, Switzerland)
Udo Hoffmann (Boston, USA)

Source: http://cannes2013.medconvent.at/pdf/Cannes2013_FinalProgram.pdf

Using the microchip endurance predictive software

Using Endurance Predictive Software Using the Microchip Endurance Predictive Software INTRODUCTION TOTAL ENDURANCE PREDICTIVE SOFTWARE Endurance, as it applies to non-volatile memory, refersto the number of times an individual memory cell can beThe predictive software described here originally waserased and/or written (some architectures do not erasebeing developed as a tool for det

fire-vols.org

1. In the patient with a blood glucose of 300mg/dL or higher without signs or symptoms of dehydration should receive how much normal saline? Pg 61 2. The adult dose of Zofran is _____. Pg 69 a. 4mg over 30 seconds IV/IO b. 4mg over 1 minute c. 2mg over 1 minute IV/IO d. 2 mg IM 3. Zofran may be given all of the following routs except_____. Pg 69 4. The pediatric dose of Zofran is _____. P

Copyright © 2010-2018 Pharmacy Drugs Pdf